# A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea

> **NCT02779413** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 3303 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** insulin degludec

## Key facts

- **NCT ID:** NCT02779413
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-02
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-06-24
- **Target enrollment:** 3303 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02779413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02779413, "A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02779413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*